EXHIBIT 4.23


DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934


 


ClearPoint
Neuro, Inc. (“ClearPoint,” “we,” “us,” and “our”)
has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”): our common stock, par value $0.01 per share (“Common Stock”).


Authorized Shares of Capital Stock 


ClearPoint’s authorized
capital stock consists of 225,000,000 shares, consisting of 200,000,000 shares
of Common Stock, and 25,000,000 shares of preferred stock, par value $.01 per share
(“Preferred Stock”).


DESCRIPTION OF COMMON
STOCK


The
following description of Common Stock is a summary and is qualified in its entirety by reference to the actual terms and
provisions contained in our Amended and Restated Certificate of Incorporation, as amended from time to time (the “Certificate
of Incorporation”), and our Second Amended and Restated Bylaws, as amended from time to time (the “Bylaws”),
each of which is filed as an exhibit to our Annual Report on Form 10-K of which this Exhibit 4.23 is a part and incorporated by
reference herein. We encourage you to read our Certificate of Incorporation, our Bylaws, and the applicable provisions of the Delaware
General Corporation Law (“DGCL”), for additional information.


Dividends


Subject to preferential
rights that may be applicable to any then outstanding preferred stock, holders of Common Stock are entitled to receive ratably
those dividends, if any, as may be declared from time to time by our board of directors out of legally available funds.


Voting Rights


Each holder of our Common
Stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of
directors. Under our Certificate of Incorporation and Bylaws, our stockholders do not have cumulative voting rights. Because of
this, the holders of a majority of the shares of Common Stock entitled to vote in any election of directors can elect all of the
directors standing for election, if they should so choose.


Liquidation Rights


In the event of our liquidation,
dissolution or winding up, after the payment of all of our debts and other liabilities and the satisfaction of any liquidation
preference granted to the holders of any outstanding shares of preferred stock, holders of Common Stock will be entitled to share
ratably in the net assets legally available for distribution to stockholders.


Fully Paid and Nonassessable


The outstanding shares of
our Common Stock are fully paid and nonassessable.


Absence of Other Rights


Holders of Common Stock
have no preemptive, conversion or subscription rights, and there are no redemption or sinking fund provisions applicable to the
Common Stock. The rights, preferences and privileges of the holders of Common Stock are subject to, and may be adversely affected
by, the rights of the holders of shares of any series of preferred stock that we may designate in the future.




     


     

    


Listing 


Our Common Stock is listed
on The Nasdaq Capital Market under the symbol “CLPT.”


Transfer Agent and Registrar


 


The transfer agent and registrar
for our Common Stock is Continental Stock Transfer & Trust Company.


 


DESCRIPTION OF PREFERRED STOCK


Under
our Certificate of Incorporation, we have 25,000,000 authorized shares of Preferred Stock, $0.01 par value per share. Our board
of directors has the authority, without further action by the stockholders, to issue up to that number of shares of Preferred Stock
in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights,
preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon,
and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.
The board of directors may authorize the issuance of Preferred Stock with voting or conversion rights that could adversely affect
the voting power or other rights of the holders of the common stock. The issuance of Preferred Stock, while providing flexibility
in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying,
deferring or preventing a change in control of the ClearPoint and may adversely affect the market price of our Common Stock and
the voting and other rights of the holders of our Common Stock. As of the date hereof, we have no shares of Preferred Stock outstanding.


CERTAIN MATTERS OF CORPORATE GOVERNANCE


Delaware Anti-Takeover Statute


We
are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, Section 203, subject
to certain exceptions, prohibits a publicly held Delaware corporation from engaging in any business combination with any interested
stockholder for a period of three years following the date that such person or entity became an interested stockholder, unless:


 


	 	•	 	prior to such date, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;


 


	 	•	 	upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding specified shares; or


 


	 	•	 	at or subsequent to such date of the transaction that resulted in a person or entity becoming an interested stockholder, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.


The
application of Section 203 may limit the ability of stockholders to approve a transaction that they may deem to be in their
best interests. In addition, Section 203 makes it more difficult for an interested stockholder to effect various business
combinations with a corporation for a three-year period, although the stockholders may, by adopting an amendment to our Certificate
of Incorporation or Bylaws, elect not to be governed by this section, effective 12 months after adoption.


In general, Section 203
defines “business combination” as:


 


	 	•	 	any merger or consolidation involving the corporation and the interested stockholder;


 


	 	•	 	any sale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or more of the assets of the corporation to or with the interested stockholder;


 


	 	•	 	subject to certain exceptions, any transaction which results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;


 


	 	•	 	any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or


 


	 	•	 	the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.


 




     


     

    


In general, Section 203 defines an “interested stockholder”
as any person that is:


 


	 	•	 	the owner of 15% or more of the outstanding voting stock of the corporation;


 


	 	•	 	an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation at any time within three years immediately prior to the relevant date; or


 


	 	•	 	an affiliate or associate of the above.


Our
Certificate of Incorporation and Bylaws do not exclude us from the restrictions imposed under Section 203. We anticipate that
the provisions of Section 203 may encourage companies interested in acquiring us to negotiate in advance with our board of
directors because the stockholder approval requirement would be avoided if a majority of the directors then in office approve either
the business combination or the transaction that resulted in the stockholder becoming an interested stockholder.


 


Certificate of Incorporation and Bylaws Provisions


 


Our Certificate of Incorporation
and Bylaws:


 


	 	•	permits our board of directors to issue shares of Preferred Stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in our control;
	 	 	 
	 	•	provides that the authorized number of directors may be changed only by resolution of the board of directors;
	 	 	 
	 	•	provides that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;
	 	 	 
	 	•	requires that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent;
	 	 	 
	 	•	provides that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing to our Secretary in a timely manner, not less than 90 nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting of stockholders, provided, however, that if the date of the annual meeting is more than 30 days before or delayed more than 30 days after such anniversary date, no proxy statement was delivered in connection with the previous year’s annual meeting, or there was no annual meeting in the preceding year, notice by the stockholder to be timely must be given, not earlier than the 90th day prior to such annual meeting and not later than the close of business on the later of the 60th day prior to such annual meeting or the 10th day following the day on which public announcement of the date of such annual meeting was first made. To be timely, a stockholder’s notice for nominations to be made at a special meeting must be made not earlier than the 120th day prior to such special meeting and not later than the 90th day prior to such special meeting or, if later, the 10th day following the day on which public announcement of the date of such special meeting was first made. Our Bylaws also specify requirements as to the form and content of a stockholder’s notice;
	 	 	 
	 	•	does not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);
	 	 	 
	 	•	provides that special meetings of our stockholders may be called only by the chairman of the board of directors, our chief executive officer or by the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors; and
	 	 	 
	 	•	provides that stockholders will be permitted to amend our Bylaws only upon receiving at least 66 2/3% of the votes entitled to be cast by holders of all outstanding shares then entitled to vote generally in the election of directors, voting together as a single class.


 


These and other provisions contained
in our Certificate of Incorporation and Bylaws could delay or discourage some types of transactions involving an actual or potential
change in our control or change in our management, including transactions in which stockholders might otherwise receive a premium
for their shares over then current prices, and may limit the ability of stockholders to remove current management or approve transactions
that stockholders may deem to be in their best interests and, therefore, could adversely affect the price of our Common Stock.